IDEX vs Mira — how do they compare? IDEX trades at Rp33.85 (market cap Rp74,11M, Rp36,08M 24h volume), while Mira trades at Rp698.2 (market cap Rp224,51M, Rp102,44M 24h volume). The key difference: Mira is far larger — about 3× IDEX's market cap, and Mira's supply is capped (321,5M / 1B MIRA (33%)) while IDEX's keeps growing. Which is the better fit depends on your goals — on Pluang, investors hold IDEX for 20 Days and Mira for 22 Days on average.
| IDEX | MIRA | |
|---|---|---|
Market Cap | Rp74,11M | Rp224,51M |
Volume (24h) | Rp36,08M | Rp102,44M |
Circulating Supply | 1B IDEX | 321,5M / 1B MIRA (33%) |
Typical Hold Time | 20 Days | 22 Days |
Signals from Pluang's Aura AI — not financial advice
IDEX token currently holds a market capitalization of Rp74,11M with 1M tokens in circulation, indicating a relatively small-cap cryptocurrency. The token shows moderate holding patterns with an average hold time of 20 days. Recent market activity suggests limited trading volume and liquidity, with the current price unavailable from verified crypto data sources. The token appears to be in a consolidation phase with minimal price volatility observed in recent trading sessions.
Overall outlook remains cautious due to limited market data and trading activity. Key opportunities include potential growth if ecosystem development accelerates, while major risks include low liquidity, limited exchange support, and vulnerability to market volatility. Investors should monitor for increased network adoption and exchange listings that could improve token accessibility and trading depth.
MIRA token trades at Rp724 with bearish technical signals as moving averages indicate strong selling pressure. The token shows neutral oscillators but faces resistance at Rp726-758 levels. With 33% circulating supply and 22-day average hold time, market participation remains limited. Recent ecosystem developments show progress in pharmaceutical research applications, though direct token utility updates are scarce.
Overall outlook remains cautious due to technical bearishness and limited trading volume. Key opportunity lies in potential protocol adoption from pharmaceutical research partnerships. Major risks include low liquidity, high volatility, and regulatory uncertainty surrounding crypto-pharma intersections. Investors should monitor exchange listings and token utility expansion.
What Pluang investors did over the last 30 days
No sentiment data available yet.
IDEX describes itself as the first hybrid liquidity DEX, merging an order book model with an automated market maker (AMM). It combines the speed and functionality of traditional order books with the security and liquidity of AMMs. By integrating an off-chain trading engine with on-chain trade settlement, IDEX offers a unique approach to decentralized exchanges.
Read more on IDEX →Mira is a decentralized verification network that enables autonomous AI by eliminating human oversight. Using consensus-based verification across multiple AI models, Mira delivers mathematically verifiable and trustless results in real time. This ensures accuracy and reliability for critical fields like healthcare, finance, and law—transforming AI from a supervised tool into truly independent intelligence.
Read more on MIRA →